Beta Drugs balance sheet

·UnclassifiedChart ›

As of Sep 2026

Total assets: ₹656cr+34.5% on Sep 2025
Shareholders' equity: ₹475crNo figure a year before
Total debt: ₹48.7crNo figure a year before
Cash and investments: ₹0.5cr+198.7% on Sep 2025

₹ crore except per share

Tap a line for its trend	H1 FY27Sep 2026	FY26Mar 2026	FY25Mar 2025

Non-current assets
	119	115	80.4
	8.8	0.0	—
	101	9.9	—
	20.1	18.0	—
	20.1	18.0	—
	3.0	2.5	1.8
	24.3	14.9	0.3
	277	161	105
Current assets
	81.9	74.5	59.8
	167	119	103
	0.5	125	0.2
	103	0.0	147
	24.2	15.4	—
	295	259	—
	2.3	1.3	12.4
	380	335	331
	656	496	436
Equity
	11.1	10.1	—
	427	235	—
	438	245	—
	37.0	0.0	0.0
	475	245	—
Liabilities
	27.8	133	—
	27.8	133	—
	3.0	2.8	—
	6.4	6.8	—
	37.2	143	136
	20.9	14.5	—
	103	80.6	71.3
	1.2	1.5	—
	126	96.6	—
	10.6	5.7	—
	8.3	5.8	21.5
	144	108	103
	182	251	—
	656	496	436
Pre-Ind-AS schedule VI — as filed
	—	—	10.1
	—	—	197
	—	—	127
	—	—	5.7
	—	—	6.8
	—	—	2.6
	—	—	4.3
	—	—	14.1
	—	—	9.3
Assets — additional as-filed lines
	—	—	88.9
	—	—	8.6
Trade payables — MSME split
	—	—	7.3
	0.0	9.3	—
	—	—	64.0
	103	71.3	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

BETA₹1,849.70

Beta Drugs Limited

· Unclassified

₹ CrorePeersTHEJO MACPOWERSAKARSERVOTECHMcap ₹1,875 Cr

View

In ₹ Crore except Per Share As of	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Non-current Assets
+ Property, Plant & Equipment	80.4	115.4	119.4
+ Capital Work-in-Progress	—	0.0	8.8
+ Other Intangibles	—	9.9	101.1
+ Other Non-current Financial Assets	—	18.0	20.1
Non-current Financial Assets	—	18.0	20.1
+ Deferred Tax Assets	1.8	2.5	3.0
+ Other Non-current Assets	0.3	14.9	24.3
Total Non-current Assets	105.2	160.6	276.7
Current Assets
+ Inventories	59.8	74.5	81.9
+ Trade Receivables	102.6	119.1	167.4
+ Cash & Cash Equivalents	0.2	124.8	0.5
+ Other Bank Balances	146.8	0.0	103.4
+ Other Current Financial Assets	—	15.4	24.2
Current Financial Assets	—	259.4	295.4
+ Other Current Assets	12.4	1.3	2.3
Total Current Assets	331.1	335.2	379.6
Total Assets	436.2	495.8	656.3
Equity
+ Equity Share Capital	—	10.1	11.1
+ Other Equity / Reserves	—	234.6	426.6
Equity — Owners of Parent	—	244.8	437.7
+ Minority Interest	0.0	0.0	37.0
Total Equity	—	244.8	474.7
Liabilities
+ Borrowings — Non-current	—	133.3	27.8
Non-current Financial Liabilities	—	133.3	27.8
+ Provisions — Non-current	—	2.8	3.0
+ Other Non-current Liabilities	—	6.8	6.4
Non-current Liabilities	136.4	142.9	37.2
+ Borrowings — Current	—	14.5	20.9
+ Trade Payables	71.3	80.6	103.5
+ Other Current Financial Liab	—	1.5	1.2
Current Financial Liabilities	—	96.6	125.5
+ Provisions — Current	—	5.7	10.6
+ Other Current Liabilities	21.5	5.8	8.3
Current Liabilities	102.8	108.1	144.4
Total Liabilities	—	251.0	181.6
Total Equity & Liabilities	436.2	495.8	656.3
Pre-Ind-AS Schedule VI — as filed
+ Share Capital	10.1	—	—
+ Shareholders' Funds	197.1	—	—
+ Long-term Borrowings	127.0	—	—
+ Short-term Borrowings	5.7	—	—
+ Other Long-term Liabilities	6.8	—	—
+ Long-term Provisions	2.6	—	—
+ Short-term Provisions	4.3	—	—
+ Long-term Loans & Advances	14.1	—	—
+ Short-term Loans & Advances	9.3	—	—
Assets — additional as-filed lines
+ PPE & Intangible Assets	88.9	—	—
+ Intangible Assets	8.6	—	—
Trade Payables — MSME split
+ Dues to Micro & Small Enterprises — alt tag	7.3	—	—
+ Dues to Micro & Small — Current	—	9.3	0.0
+ Dues to Other Creditors — alt tag	64.0	—	—
+ Dues to Other Creditors — Current	—	71.3	103.5
Other Filed Concepts — mapped but not yet placed in the schedule
Reserves	187.0	—	—

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.